' '
Deutsch | English    

Research Database PMU-SQQUID

MAYR CHRISTIAN REINHARD
Department of Internal Medicine I - Division of Gastroenterology, Hepatology, Nephrology, Metabolism and Diabetology
Institute of Physiology and Pathophysiology

Publications | Researcher Profile

84 Publications

2023

Journal Articles

Evaluation of Tazemetostat as a Therapeutically Relevant Substance in Biliary Tract Cancer.
Bekric, D; Neureiter, D; Ablinger, C; Dobias, H; Beyreis, M; Ritter, M; Jakab, M; Bischof, J; Koller, U; Kiesslich, T; Mayr, C;
Cancers (Basel). 2023; 15(5):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
HDACs as an emerging target in endocrine tumors: a comprehensive review.
Klieser, E; Neumayer, B; Di Fazio, P; Mayr, C; Neureiter, D; Kiesslich, T;
Expert Rev Endocrinol Metab. 2023; 18(2):143-154
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

2022

Journal Articles

Ferroptosis in Hepatocellular Carcinoma: Mechanisms, Drug Targets and Approaches to Clinical Translation.
Bekric, D; Ocker, M; Mayr, C; Stintzing, S; Ritter, M; Kiesslich, T; Neureiter, D;
Cancers (Basel). 2022; 14(7):
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Chemoresistance and resistance to targeted therapies in biliary tract cancer: what have we learned?
Mayr, C; Kiesslich, T; Modest, DP; Stintzing, S; Ocker, M; Neureiter, D;
Expert Opin Investig Drugs. 2022; 31(2): 221-233.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
MicroRNA mimics can distort physiological microRNA effects on immune checkpoints by triggering an antiviral interferon response.
Prinz, F; Jonas, K; Balihodzic, A; Klec, C; Reicher, A; Barth, DA; Riedl, J; Gerger, A; Kiesslich, T; Mayr, C; Rinner, B; Kargl, J; Pichler, M;
RNA Biol. 2022; 19(1): 1305-1315.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
New method for real-time visualization and quantitative characterization of early colorectal cancer in endoscopy: a pilot study.
Wagner, A; Zandanell, S; Ziachehabi, A; Mitrakov, A; Klieser, E; Neureiter, D; Kiesslich, T; Mayr, C; Berr, F; Fedoruk, M; Singhartinger, F; Holzinger, J;
Endosc Int Open. 2022; 10(8):E1147-E1154
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Conference papers, proceedings, abstracts

Cdk5 as a possible new target in biliary tract cancer: preliminary in-situ findings.
Wilhelm, F; Klieser, E; Neumayer, B; Winkelmann, P; Jäger, T; Pachmayr, J; Ardelt, M; Huber-Cantonati, P; Ablinger, C; Pancis, I; Ritter, M; Kiesslich, T; Mayr, C; Neureiter, D
Zeitschrift für Gastroenterologie.. 2022; 60(01):e32-e32.-38. Jahrestagung der Deutschen Arbeitsgemeinschaft zum Studium der Leber; 28.-29.01.2022; Mannheim.
Abstracts (Journal)
Abstract/Keywords Full Text

2021

Journal Articles

HDAC Screening Identifies the HDAC Class I Inhibitor Romidepsin as a Promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C; Kiesslich, T; Erber, S; Bekric, D; Dobias, H; Beyreis, M; Ritter, M; Jäger, T; Neumayer, B; Winkelmann, P; Klieser, E; Neureiter, D;
Cancers (Basel). 2021; 13(15):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
HDAC-targeting epigenetic drug screening for biliary tract cancer.
Mayr, C; Kiesslich, T; Erber, S; Bekric, D; Dobias, H; Ritter, M; Jäger, T; Neumayer, B; Winkelmann, P; Klieser, E; Neureiter, D;
Ann Hepatobiliary Pancreat Surg. 2021; 25(Suppl 1): S397
Notes
Abstract/Keywords PubMed Full Text
The challenges of combinatory immunotherapy for biliary tract cancer.
Neureiter, D; Mayr, C; Kiesslich, T;
Expert Opin Investig Drugs. 2021; 30(6):591-594
Editorials
Abstract/Keywords Web of Science PubMed Full Text
Immunmodulatory Treatment Strategies of Hepatocellular Carcinoma: From Checkpoint Inhibitors Now to an Integrated Approach in the Future.
Ocker, M; Mayr, C; Kiesslich, T; Stintzing, S; Neureiter, D;
Cancers (Basel). 2021; 13(7):
Reviews
Abstract/Keywords Web of Science PubMed Full Text
MiR-200c-3p Modulates Cisplatin Resistance in Biliary Tract Cancer by ZEB1-Independent Mechanisms.
Posch, F; Prinz, F; Balihodzic, A; Mayr, C; Kiesslich, T; Klec, C; Jonas, K; Barth, DA; Riedl, JM; Gerger, A; Pichler, M;
Cancers (Basel). 2021; 13(16):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Unpublished conference presentations

HDAC-targeting Epigenetic Drug Screening for Biliary Tract Cancer.
Mayr, C; Kiesslich, T; Erber, S; Bekric, D; Dobias, H; Ritter, M; Jäger, T; Neumayer, B. Winkelmann, P; Klieser, E; Neureiter, D
HBP Surgery Week 2021 & 54th Annual Congress of the Korean Association of HBP Surgery; 25.03.-27.03.2021; Seoul. 2021.
Abstract/Keywords
HDAC Class I Inhibitor Romidepsin as a novel and promising Epigenetic Drug for Biliary Tract Cancer.
Mayr, C; Kiesslich, T; Erber, S; Bekric, D; Dobias, H; Ritter, M; Jäger, T; Neumayer, B. Winkelmann, P; Klieser, E; Neureiter, D
Cholangiocarcinoma Foundation (CCF) Annual Conference 2021; 31.03.-02.04.2021; Herriman, Utah (virtuell). 2021.
Abstract/Keywords

2020

Journal Articles

Long Non-Coding RNAs in Biliary Tract Cancer-An Up-to-Date Review.
Bekric, D; Neureiter, D; Ritter, M; Jakab, M; Gaisberger, M; Pichler, M; Kiesslich, T; Mayr, C;
J Clin Med. 2020; 9(4):
Reviews
Abstract/Keywords Web of Science PubMed Full Text
How do we choose the appropriate chemotherapeutic agents for biliary tract cancer?
Neureiter, D; Mayr, C; Kiesslich, T;
Expert Opin Pharmacother. 2020; 21(3):243-245
Editorials
Abstract/Keywords Web of Science PubMed Full Text
Expression of the microRNA-200 Family, microRNA-205, and Markers of Epithelial-Mesenchymal Transition as Predictors for Endoscopic Submucosal Dissection over Esophagectomy in Esophageal Adenocarcinoma: A Single-Center Experience.
Neureiter, D; Mayr, C; Winkelmann, P; Neumayer, B; Klieser, E; Wagner, A; Hufnagl, C; Emmanuel, K; Holzinger, J; Koch, O; Kiesslich, T; Varga, M;
Cells. 2020; 9(2):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

Markers of epithelial-mesenchymal-transition in oesophageal adenocarcinoma for decision strategy of surgical versus endoscopic therapy
Neureiter, D; Mayr, C; Winkelmann, P; Neumayer, ; Klieser, E; Wagner, A; Hufnagl, C; Emmanuel, K; Holzinger, J; Koch, O; Kiesslich, T; Varga, M
Markers of epithelial-mesenchymal-transition in oesophageal adenocarcinoma for decision strategy of surgical versus endoscopic therapy . 2020; 477(Suppl. 1):S192-S192.-32nd Congress of the ESP and XXXIII International Congress of the IAP; 06.-08.12.2020; Glasgow.
Abstracts (Journal)
Abstract/Keywords Full Text

2019

Journal Articles

The Cancer Stem Cell Inhibitor Napabucasin (BBI608) Shows General Cytotoxicity in Biliary Tract Cancer Cells and Reduces Cancer Stem Cell Characteristics.
Beyreis, M; Gaisberger, M; Jakab, M; Neureiter, D; Helm, K; Ritter, M; Kiesslich, T; Mayr, C;
Cancers (Basel). 2019; 11(3):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
NRF2: The key to tumor- and patient-dependent chemosensitivity in biliary tract cancer?
Kiesslich, T; Mayr, C; Neureiter, D;
EBioMedicine. 2019; 49:9-10
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Acid- and Volume-Sensitive Chloride Currents in Microglial Cells.
Kittl, M; Helm, K; Beyreis, M; Mayr, C; Gaisberger, M; Winklmayr, M; Ritter, M; Jakab, M;
Int J Mol Sci. 2019; 20(14):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
The Crosstalk of miRNA and Oxidative Stress in the Liver: From Physiology to Pathology and Clinical Implications.
Klieser, E; Mayr, C; Kiesslich, T; Wissniowski, T; Fazio, PD; Neureiter, D; Ocker, M;
Int J Mol Sci. 2019; 20(21):
Reviews
Abstract/Keywords Web of Science PubMed Full Text
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement.
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Fuchs, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Cell Adh Migr. 2019; 13(1):76-82
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Pancreatic cancer in young adults: changes, challenges, and solutions.
Primavesi, F; Stättner, S; Schlick, K; Kiesslich, T; Mayr, C; Klieser, E; Urbas, R; Neureiter, D;
Onco Targets Ther. 2019; 12: 3387-3400.
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Unpublished conference presentations

The cancer stem cell inhibitor napabucasin (BBI608) shows general cytotoxicity in biliary tract cancer cells and reduces cancer stem cell characteristics
Beyreis, M; Gaisberger, Martin; Jakab, M; Neureiter, D; Helm, K; Ritter, M; Kiesslich, T; Mayr, C;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.03.2019; Nürnberg. 2019.
Abstract/Keywords
The cancer stem cell inhibitor napabucasin (BBI608) shows general cytotoxicity in biliary tract cancer cells and reduces cancer stem cell characteristics
Beyreis,M; Gaisberger, M; Jakab, M; Neureiter, D; Helm,K; Ritter, M; Kiesslich, T; Mayr, C;
PMU Science Get Together 2019; 28.06.2019; Nürnberg. 2019.
Abstract/Keywords
Establishing the cardiotonic steroid ouabain as a potent anti-cancer drug against biliary tract cancer – Step one
Heidemarie, D; Kiesslich, T; Kittl, M; Gaisberger, M; Jakab, M; Mayr, C;
11th ÖGMBT Annual Meeting; 16.-18.9.2019; Salzburg. 2019.
Abstract/Keywords
Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.3.2019; Nürnberg. 2019.
Abstract/Keywords
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
7th Symposium of the Young Physiologists and Pharmacologists; 14.-15.03.2019; Nürnberg. 2019.
Abstract/Keywords

2018

Journal Articles

Glycine Induces Migration of Microglial BV-2 Cells via SNAT-Mediated Cell Swelling.
Kittl, M; Dobias, H; Beyreis, M; Kiesslich, T; Mayr, C; Gaisberger, M; Ritter, M; Kerschbaum, HH; Jakab, M;
Cell Physiol Biochem. 2018; 50(4): 1460-1473.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
HDAC-Linked "Proliferative" miRNA Expression Pattern in Pancreatic Neuroendocrine Tumors.
Klieser, E; Urbas, R; Swierczynski, S; Stättner, S; Primavesi, F; Jäger, T; Mayr, C; Kiesslich, T; Fazio, PD; Helm, K; Neureiter, D;
Int J Mol Sci. 2018; 19(9):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Miniaturization of the Clonogenic Assay Using Confluence Measurement.
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2018; 19(3):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer.
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Hum Pathol. 2018; 72:117-126
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Update on the role and therapeutic potential of polycomb repressive complexes in (biliary tract) cancer.
Neureiter, D; Kiesslich, T; Ritter, M; Mayr, C;
Expert Opin Ther Targets. 2018; 22(1): 1-3.
Editorials
Abstract/Keywords Web of Science PubMed Full Text
Single-center implementation of endoscopic submucosal dissection (ESD) in the colorectum: Low recurrence rate after intention-to-treat ESD.
Wagner, A; Neureiter, D; Kiesslich, T; Wolkersdörfer, GW; Pleininger, T; Mayr, C; Dienhart, C; Yahagi, N; Oyama, T; Berr, F;
Dig Endosc. 2018; 30(3):354-363
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Pharmacological Inhibition of Class IIA HDACs by LMK-235 in Pancreatic Neuroendocrine Tumor Cells.
Wanek, J; Gaisberger, M; Beyreis, M; Mayr, C; Helm, K; Primavesi, F; Jäger, T; Di Fazio, P; Jakab, M; Wagner, A; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2018; 19(10):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Unpublished conference presentations

Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords
Evaluation of Napabucasin as a direct inhibitor of cancer stem cells in biliary tract cancer
Beyreis, M; Gaisbberger, M; Helm, K; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords
Evaluation of Napabucasin as a direct inhibitor of cancer stem cells in biliary tract cancer
Beyreis, M; Gaisberger, M; Helm, K; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T; Mayr, C;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Abstract/Keywords
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Landrichinger, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Abstract/Keywords
Continuous, label-free, 96-well-based determination of cell migration using confluence measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Lanrichinger, J; Pichler, M; Ritter, M; Jakab, M; Helm, K; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords
Miniaturization of the Clonogenic Assay Using Confluence Measurement
Mayr, C; Beyreis, M; Dobias, H; Gaisberger, M; Pichler, M; Ritter, M; Jakab, M; Neureiter, D; Kiesslich, T;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Abstract/Keywords
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Jahrestagung Österreichische Physiologische Gesellschaft; 04.10.2018; Salzburg. 2018.
Abstract/Keywords
The histone methyltransferase G9a: a new therapeutic target in biliary tract cancer
Mayr, C; Helm, K; Jakab, M; Ritter, M; Shrestha, R; Makaju, R; Wagner, A; Pichler, M; Beyreis, M; Staettner, S; Jaeger, T; Klieser, E; Kiesslich, T; Neureiter, D;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords
Isolation and initial characterization of biliary tract cell-derived exosomes
Stangassigner, L; Beyreis, M; Dobias, H; Pichler, M; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords
HDAC5 as a novel pharmacological target in pancreatic neuroendocrine tumor cells
Wanek; J; Gaisberger, M; Beyreis, M; Mayr, C; Primnavesi, F; DiFazio, F; Jakab, M; Neureiter, D; Kiesslich, T;
Paracelsus Science Get Together 2018; 04.07.2018; Salzburg. 2018.
Abstract/Keywords

2017

Journal Articles

In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis.
Helm, K; Beyreis, M; Mayr, C; Ritter, M; Jakab, M; Kiesslich, T; Plaetzer, K;
Cell Physiol Biochem. 2017; 41(3): 1011-1019.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
IMP2/IGF2BP2 expression, but not IMP1 and IMP3, predicts poor outcome in patients and high tumor growth rate in xenograft models of gallbladder cancer.
Kessler, SM; Lederer, E; Laggai, S; Golob-Schwarzl, N; Hosseini, K; Petzold, J; Schweiger, C; Reihs, R; Keil, M; Hoffmann, J; Mayr, C; Kiesslich, T; Pichler, M; Kim, KS; Rhee, H; Park, YN; Lax, S; Obrist, P; Kiemer, AK; Haybaeck, J;
Oncotarget. 2017; 8(52): 89736-89745.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Comprehensive immunohistochemical analysis of histone deacetylases in pancreatic neuroendocrine tumors: HDAC5 as a predictor of poor clinical outcome.
Klieser, E; Urbas, R; Stättner, S; Primavesi, F; Jäger, T; Dinnewitzer, A; Mayr, C; Kiesslich, T; Holzmann, K; Di Fazio, P; Neureiter, D; Swierczynski, S;
Hum Pathol. 2017; 65: 41-52.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Biliary tract cancer stem cells - translational options and challenges.
Mayr, C; Ocker, M; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T;
World J Gastroenterol. 2017; 23(14): 2470-2482.
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
Reduced complication rates of percutaneous transhepatic biliary drainage with ultrasound guidance.
Wagner, A; Mayr, C; Kiesslich, T; Berr, F; Friesenbichler, P; Wolkersdörfer, GW;
J Clin Ultrasound. 2017; 45(7): 400-407.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

The effect of Napabucasin on cancer stem cells in biliary tract cancer
Beyreis, M; Helm, K; Dobias, H; Jakab, M; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C
ACTA PHYSIOL. 2017; 221: 252-252.
Abstracts (Journal)
Abstract/Keywords Web of Science
In Vitro Cell Death Discrimination and Screening Method by Simple and Cost-Effective Viability Analysis
Helm, K; Beyreis, M; Mayr, C; Ritter, M; Jakab, M; Kiesslich, T; Platzer, K
ACTA PHYSIOL. 2017; 221: 176-176.
Abstracts (Journal)
Abstract/Keywords Web of Science
The histone-modification complex G9a and its role in biliary tract cancer/cholangiocarcinoma
Helm, K; Mayr, C; Beyreis, M; Ritter, M; Jakab, M; Klieser, E; Kiesslich, T; Neureiter, D
ACTA PHYSIOL. 2017; 221: 252-252.
Abstracts (Journal)
Abstract/Keywords Web of Science
Expression pattern of histone deacetylases in gastrointestinal stromal tumors compared to clinic-pathological data
Klieser, E; Schmidt, J; Jäger, T; Mayr, C; Urbas, R; Kiesslich, T; Neureiter, D
Der Pathologe. 2017; 38(Supp. 1):S133-S133.-101. Jahrestagung der Deutschen Gesellschaft für Pathologie e.V.; 22.-24.06.2017; Erlangen.
Abstracts (Journal)
Abstract/Keywords
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in binary tract cancer cells
Mayr, C; Wagner, A; Loffelberger, M; Bruckner, D; Jakab, M; Berr, F; Fazio, P; Ocker, M; Neureiters, D; Pichler, M; Kiesslich, T
ACTA PHYSIOL. 2017; 221: 250-252.
Abstracts (Journal)
Abstract/Keywords Web of Science

Newspaper/magazine articles

Krebsstammzellen beim Melanom – von der Definition zur Therapie
Mayr, C; Neureiter, D; Kiesslich, T
JATROS Dermatologie & Plastische Chirurgie. 2017. 1: 10-13.
Abstract/Keywords

2016

Journal Articles

Differential role of Hedgehog signaling in human pancreatic (patho-) physiology: An up to date review.
Klieser, E; Swierczynski, S; Mayr, C; Jäger, T; Schmidt, J; Neureiter, D; Kiesslich, T; Illig, R;
World J Gastrointest Pathophysiol. 2016; 7(2): 199-210.
Reviews
Abstract/Keywords PubMed Full Text
Deregulated MicroRNAs in Biliary Tract Cancer: Functional Targets and Potential Biomarkers.
Mayr, C; Beyreis, M; Wagner, A; Pichler, M; Neureiter, D; Kiesslich, T;
Biomed Res Int. 2016; 2016:4805270
Reviews
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
The BMI1 inhibitor PTC-209 is a potential compound to halt cellular growth in biliary tract cancer cells.
Mayr, C; Wagner, A; Loeffelberger, M; Bruckner, D; Jakab, M; Berr, F; Di Fazio, P; Ocker, M; Neureiter, D; Pichler, M; Kiesslich, T;
Oncotarget. 2016; 7(1): 745-758.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Comprehensive Analysis of miRNome Alterations in Response to Sorafenib Treatment in Colorectal Cancer Cells
Pehserl, AM; Ress, AL; Stanzer, S; Resel, M; Karbiener, M; Stadelmeyer, E; Stiegelbauer, V; Gerger, A; Mayr, C; Scheideler, M; Hutterer, GC; Bauernhofer, T; Kiesslich, T; Pichler, M
INT J MOL SCI. 2016; 17(12): 2011
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Relevance of MicroRNA200 Family and MicroRNA205 for Epithelial to Mesenchymal Transition and Clinical Outcome in Biliary Tract Cancer Patients.
Urbas, R; Mayr, C; Klieser, E; Fuereder, J; Bach, D; Stättner, S; Primavesi, F; Jaeger, T; Stanzer, S; Ress, AL; Löffelberger, M; Wagner, A; Berr, F; Ritter, M; Pichler, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2016; 17(12):
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Unpublished conference presentations

A modified viability assay for simple and cost-effective in vitro determination of cell death modes
Helm, K; Hasenleitner, M; Mayr, C; Beyreis, M; Jakab, M; Neureiter, D; Plaetzer, K; Kiesslich, T;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.
Abstract/Keywords
Establishment and validation of a cell-based fluorimetric method for measurement of HDL-based cholesterol efflux capacity from macrophages.
Muehlbacher, S; Kiesslich, T; Mayr, C; Kedenko, L; Paulweber, B;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.
Abstract/Keywords
Pre-clinical evaluation of novel specific PRC2 inhibitors as potential experimental therapies in biliary tract cancer
Stangassinger, L; Beyreis, M; Helm, K; Ritter, M; Neureiter, D; Kiesslich, T; Mayr, C;
Paracelsus Science Get Together 2016; 29.06.2016; Salzburg. 2016.
Abstract/Keywords

2015

Journal Articles

The pan-deacetylase inhibitor panobinostat affects angiogenesis in hepatocellular carcinoma models via modulation of CTGF expression.
Gahr, S; Mayr, C; Kiesslich, T; Illig, R; Neureiter, D; Alinger, B; Ganslmayer, M; Wissniowski, T; Fazio, PD; Montalbano, R; Ficker, JH; Ocker, M; Quint, K;
Int J Oncol. 2015; 47(3):963-970
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
Role of histone deacetylases in pancreas: Implications for pathogenesis and therapy.
Klieser, E; Swierczynski, S; Mayr, C; Schmidt, J; Neureiter, D; Kiesslich, T; Illig, R;
World J Gastrointest Oncol. 2015; 7(12): 473-483.
Reviews
Abstract/Keywords Web of Science PubMed Full Text
Cytotoxic effects of chemokine receptor 4 inhibition by AMD3100 in biliary tract cancer cells: Potential drug synergism with gemcitabine.
Mayr, C; Neureiter, D; Pichler, M; Berr, F; Wagner, A; Kiesslich, T; Namberger, K;
Mol Med Rep. 2015; 12(2):2247-2252
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
The role of polycomb repressive complexes in biliary tract cancer.
Mayr, C; Neureiter, D; Wagner, A; Pichler, M; Kiesslich, T;
Expert Opin Ther Targets. 2015; 19(3):363-375
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
The green tea catechin epigallocatechin gallate induces cell cycle arrest and shows potential synergism with cisplatin in biliary tract cancer cells.
Mayr, C; Wagner, A; Neureiter, D; Pichler, M; Jakab, M; Illig, R; Berr, F; Kiesslich, T;
BMC Complement Altern Med. 2015; 15:194
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text
3-Deazaneplanocin A May Directly Target Putative Cancer Stem Cells in Biliary Tract Cancer.
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DI Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T;
Anticancer Res. 2015; 35(9): 4697-4705.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed
Neoadjuvant Down-Sizing of Hilar Cholangiocarcinoma with Photodynamic Therapy-Long-Term Outcome of a Phase II Pilot Study.
Wagner, A; Wiedmann, M; Tannapfel, A; Mayr, C; Kiesslich, T; Wolkersdörfer, GW; Berr, F; Hauss, J; Witzigmann, H;
Int J Mol Sci. 2015; 16(11): 26619-26628.
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text

Conference papers, proceedings, abstracts

Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
ACTA PHYSIOL. 2015; 213: 148-148.
Abstracts (Journal)
Abstract/Keywords Web of Science
DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
Mayr, C; Wagner, A; Stoecklinger, A; Jakab, M; Illig, R; Berr, F; Pichler, M; Di Fazio, P; Ocker, M; Neureiter, D; Kiesslich, T
ACTA PHYSIOL. 2015; 213: 147-148.
Abstracts (Journal)
Abstract/Keywords Web of Science

Newspaper/magazine articles

P190: DZNep directly targets putative cancer stem cells in biliary tract cancer cells by inhibition of polycomb repressive complex 2
Mayr, C; Stoecklinger, A; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DiFazio, P; Ocker, M; Neureiter, D; Kiesslich, T
Acta Physiologica. 2015. 213: 147-148.
Abstract/Keywords Full Text
Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr C; Wagner A; Beyreis M; Illig R; Berr F; Pichler M; Di Fazio P; Neureiter D; Kiesslich T
Zeitschrift für Gastroenterologie. 2015. 05/2015: 505-505.
Abstract/Keywords
P191: Treatment of biliary tract cancer cells with polycomb repressive complex 1 inhibitor PTC-209 reduces putative cancer stem cell population and causes cell cycle arrest
Mayr, C; Wagner, A; Jakab, M; Illig, R; Berr, F; Pichler, M; DiFazio, P; Ocker, M; Neureiter, D; Kiesslich, T
Acta Physiologica. 2015. 213: 148-148.
Abstract/Keywords Full Text
Green tea catechin epigallocatechin gallate causes apoptosis and shows potential synergism with cisplatin in biliary tract cancer cells
Mayr C; Wagner A; Neureiter D; Pichler M; Ritter M; Illig R; Berr F; Kiesslich T
Zeitschrift für Gastroenterologie. 2015. 05/2015: 504-505.
Abstract/Keywords

2014

Journal Articles

Activated hedgehog pathway is a potential target for pharmacological intervention in biliary tract cancer.
Kiesslich, T; Mayr, C; Wachter, J; Bach, D; Fuereder, J; Wagner, A; Alinger, B; Pichler, M; Di Fazio, P; Ocker, M; Berr, F; Neureiter, D;
Mol Cell Biochem. 2014; 396(1-2):257-268
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed Full Text
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Pichler, M; Neureiter, D; Kiesslich, T;
Int J Mol Sci. 2014; 15(11):20134-20157
Full papers/articles (Journal)
Abstract/Keywords Web of Science PubMed PUBMED Central Full Text

Conference papers, proceedings, abstracts

PRC2 inhibition may directly target putative cancer stem cells in biliary tract cancer cell lines.
Mayr, C; Wagner, A; Illig, R; Pichler, M; Berr, F; Neureiter, D; Kiesslich, T;
Pathophysiology and Treatment of Cholangiocarcinoma. 2014; -Falk Workshop; 23.-24.01.2014; Tübingen.
Abstracts (Journal)
Abstract/Keywords
MicroRNAs associated with the efficacy of photodynamic therapy in biliary tract cancer cell lines.
Wagner, A; Mayr, C; Bach, D; Illig, R; Plaetzer, K; Berr, F; Neureiter, D; Kiesslich, T;
Abstract Band - Pathophysiology and Treatment of Cholangiocarcinoma. 2014; -Falk Workshop; 23.-24.01.2014; Tübingen.
Abstracts (Journal)
Abstract/Keywords

Newspaper/magazine articles

KG 164: Epithelial-mesenchymal transition-associated microRNA expression pattern in human biliary tract cancer: a clinical and pathological approach
Ilig, R; Kiesslich, T; Kemmerling, R; Alinger, B; Klieser, E; Berr, F; Neureiter, D
Zeitschrift für Gastroenterologie. 2014. 52: KG164-KG164.
Abstract/Keywords Full Text
DZNep may directly target putative cancer stem cells in biliary tract cancer cells by inhibition of PRC2
Mayr, C; Wagner, A; Stöcklinger, A; Jakab, M; Illig, R; Pichler, M; Berr, F; Neureiter, D; Kiesslich, T
Zeitschrift für Gastroenterologie. 2014. 52: KG167-KG167.
Abstract/Keywords Full Text